Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Shares Outstanding (Weighted Average) (2018 - 2024)

Historic Shares Outstanding (Weighted Average) for ImmunoTech (AIM) over the last 8 years, with Q4 2024 value amounting to $56.0 million.

  • ImmunoTech's Shares Outstanding (Weighted Average) rose 1529.57% to $56.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $56.0 million, marking a year-over-year increase of 1529.57%. This contributed to the annual value of $56.0 million for FY2024, which is 1529.57% up from last year.
  • Latest data reveals that ImmunoTech reported Shares Outstanding (Weighted Average) of $56.0 million as of Q4 2024, which was up 1529.57% from $48.6 million recorded in Q4 2023.
  • Over the past 5 years, ImmunoTech's Shares Outstanding (Weighted Average) peaked at $38.9 billion during Q3 2020, and registered a low of $17.5 million during Q1 2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $48.6 million (2023), whereas its average is $6.5 billion.
  • Data for ImmunoTech's Shares Outstanding (Weighted Average) shows a peak YoY increase of 1529.57% (in 2024) and a maximum YoY decrease of 1529.57% (in 2024) over the last 5 years.
  • Over the past 3 years, ImmunoTech's Shares Outstanding (Weighted Average) (Quarter) stood at $38.9 billion in 2020, then tumbled by 99.88% to $48.6 million in 2023, then increased by 15.3% to $56.0 million in 2024.
  • Its last three reported values are $56.0 million in Q4 2024, $48.6 million for Q4 2023, and $48.6 million during Q3 2023.